AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON JUNE 30, 2005
Registration No. 333-
================================================================================
--------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------------------
FORM S-8
REGISTRATION STATEMENT UNDER
THE SECURITIES ACT OF 1933
----------------------
CELGENE CORPORATION
(Exact name of Registrant as specified in its Charter)
DELAWARE 22-2711928
(State or other jurisdiction of (I.R.S. Employer Identification No.)
incorporation or organization)
86 MORRIS AVENUE
SUMMIT, NEW JERSEY 07901
(Address of principal executive offices) (Zip code)
----------------------
CELGENE CORPORATION 1998 STOCK INCENTIVE PLAN*
CELGENE CORPORATION 1995 NON-EMPLOYEE DIRECTORS' INCENTIVE PLAN
(Full Title of the Plans)
----------------------
John W. Jackson COPIES TO:
Celgene Corporation Robert A. Cantone, Esq.
86 Morris Avenue Proskauer Rose LLP
Summit, New Jersey 07901 1585 Broadway
(Name and Address of Agent for Service) New York, New York 10036-8299
(908) 673-9000 (212) 969-3000
(Telephone number, including area code,
of agent for service)
-----------------------------
CALCULATION OF REGISTRATION FEE
---------------------------------------------------------------------------------------------------------------------
PROPOSED MAXIMUM PROPOSED MAXIMUM AMOUNT OF
TITLE OF SECURITIES AMOUNT TO BE OFFERING PRICE AGGREGATE OFFERING REGISTRATION
TO BE REGISTERED REGISTERED PER SHARE PRICE FEE (1)
---------------------------------------------------------------------------------------------------------------------
Common Stock, par 6,250,000 (2) $40.55(3) $253,437,500(3) $29,830
value $.01 per share
---------------------------------------------------------------------------------------------------------------------
*Known prior to April 23, 2003 as the 1998 Long-Term Incentive Plan.
(1) Pursuant to General Instruction E to Form S-8, a filing fee is only being
paid with respect to the registration of additional securities for the
Celgene Corporation 1998 Stock Incentive Plan (the "1998 Plan") and the
Celgene Corporation 1995 Non-Employee Directors' Incentive Plan (the
"Directors' Incentive Plan" and, together with the 1998 Plan, the "Plans").
A Registration Statement on Form S-8 has previously been filed on each of
January 4, 1999 (Registration No. 333-70083), June 20, 2000 and March 20,
2001 (Registration No. 333-39716), July 26, 2001 (Registration No.
333-65908) and August 14, 2003 (Registration No. 333-107980) for the
existing securities under the 1998 Plan. A Registration Statement on Form
S-8 has previously been filed on December 2, 1999 (Registration No.
333-91977) for the existing securities under the Directors' Incentive Plan.
(2) Represents the additional number of shares of common stock, par value $.01
per share ("Common Stock"), issuable upon exercise of options which may be
granted under the Plans.
(3) Calculated solely for purposes of this offering under Rules 457(c) and
457(h) of the Securities Act of 1933, as amended, on the average of the
high and low selling prices per share of the Common Stock as reported on
the NASDAQ National Market on June 24, 2005.
2
Explanatory Note
This Registration Statement is filed pursuant to General Instruction E to
Form S-8. The contents of each of the Registration Statements on Form S-8
(Registration Nos. 333-70083, 333-39716, 333-65908 and 333-107980 with respect
to the 1998 Plan and Registration No. 333-91977 with respect to the Directors'
Incentive Plan) are incorporated herein by reference and made a part hereof.
1. REGISTRATION OF ADDITIONAL SHARES OF COMMON STOCK UNDER THE 1998 PLAN.
The aggregate number of shares of Common Stock that may be subject to awards
under the 1998 Plan is increased from 25,000,000 to 31,000,000 and the number of
shares that may be used for awards of restricted stock or performance-based
awards denominated in shares of common stock is decreased from 1,700,000 to
750,000.
2. REGISTRATION OF ADDITIONAL SHARES OF COMMON STOCK UNDER THE DIRECTORS'
INCENTIVE PLAN. The aggregate number of shares of Common Stock that may be
subject to awards under the Directors' Incentive Plan is increased from
3,600,000 to 3,850,000 and the period under which options may be granted is
extended until June 30, 2015.
3
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
ITEM 3. INCORPORATION OF DOCUMENTS BY REFERENCE.
The contents of each of the Registration Statements on Form S-8 previously
filed with the Securities and Exchange Commission (the "Commission") on January
4, 1999 (Registration No. 333-70083), December 2, 1999 (Registration No.
333-91977), June 20, 2000 (Registration No. 333-39716), March 20, 2001,
Post-Effective Amendment No. 1 with a Reoffer Prospectus (Registration No.
333-39716), July 26, 2001 (Registration No. 333-65908) and August 14, 2003
(Registration No. 333-107980) by Celgene Corporation, a Delaware corporation
(the "Corporation" or the "Registrant"), are incorporated herein by reference.
In addition, the following new documents filed with the Commission by the
Corporation are incorporated herein by reference:
(1) the Corporation's Annual Report on Form 10-K for the fiscal year ended
December 31, 2004, filed with the Commission on March 16, 2005, as amended by
Form 10-K/A and filed with the Commission on March 18 and 21, 2005;
(2) the Corporation's Quarterly Reports on Form 10-Q for the fiscal
quarters ended March 31, 2005 filed with the Commission on May 10, 2005;
(3) the Corporation's Current Reports on Form 8-K and Form 8-K/A filed with
the Commission on January 5 and 27, 2005, February 22, 2005, March 17 and 29,
2005, April 28, 2005 and June 16, 2005;
(4) the description of the Corporation's Common Stock contained in the
Corporation's Registration Statement on Form 8-A, File No. 0-16132; and
(5) all documents subsequently filed by the Corporation pursuant to
Sections 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, prior
to the filing of a post-effective amendment which indicates that all securities
offered have been sold or which deregisters all securities then remaining
unsold, shall be deemed to be incorporated by reference in this Registration
Statement and to be part hereof from the date of filing such documents.
Any statement contained herein or in a document incorporated or deemed to be
incorporated by reference herein shall be deemed to be modified or superseded
for purposes of this Registration Statement to the extent that a statement
contained herein or in any other subsequently filed document which also is or is
deemed to be incorporated by reference herein modifies or supersedes such
statement. Any statement so modified or superseded shall not be deemed, except
as so modified or superseded, to constitute a part of this Registration
Statement.
ITEM 8. EXHIBITS.
------ ---------
5.1 Opinion of Proskauer Rose LLP.
23.1 Consent of KPMG LLP.
23.2 Consent of Proskauer Rose LLP (included in Exhibit 5.1).
24.1 Power of Attorney (included in signature pages).
99.1 Celgene Corporation 1998 Stock Incentive Plan, as amended and
restated.
99.2 Celgene Corporation 1995 Non-Employee Directors' Incentive Plan,
as amended and restated.
II-I
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the
Registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form S-8 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Summit, State of New Jersey, on June 30, 2005.
CELGENE CORPORATION
By: /s/ John W. Jackson
--------------------------
John W. Jackson
Chairman of the Board and
Chief Executive Officer
SIGNATURES AND POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS that each person whose signature appears
below constitutes and appoints John W. Jackson, Sol J. Barer and Robert J.
Hugin, and each of them, his or her true and lawful attorneys-in-fact and
agents, with full power of substitution and resubstitution, to act, without the
other, for him or her and in his or her name, place and stead, in any and all
capacities, to sign a Registration Statement on Form S-8 of Celgene Corporation
(the "Corporation") and any or all amendments (including post-effective
amendments) thereto, relating to the registration, under the Securities Act of
1933, as amended, of additional shares of Common Stock of the Corporation to be
issued pursuant to the Corporation's 1998 Stock Incentive Plan and the
Directors' Incentive Plan and to file the same, with all exhibits thereto, and
other documents in connection therewith, with the Securities and Exchange
Commission, granting unto said attorneys-in-fact and agents full power and
authority to do and perform each and every act and thing requisite and necessary
to be done in and about the premises, as full to all intents and purposes as he
or she might or could do in person, hereby ratifying and confirming all that
said attorneys-in-fact and agents, or any of them, their substitute or
substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, as amended,
this Registration Statement has been signed on June 30, 2005 below by the
following persons in the capacities indicated.
Signature Title
--------- -----
/s/ John W. Jackson Chairman of the Board and Chief
-------------------------------- Executive Officer (Principal
John W. Jackson Executive Officer)
/s/ Sol J. Barer Director, Chief Operating Officer
--------------------------------
Sol J. Barer
/s/ Robert J. Hugin Director, Chief Financial Officer
--------------------------------
Robert J. Hugin
/s/ Jack L. Bowman Director
--------------------------------
Jack L. Bowman
/s/ Frank T. Cary Director
--------------------------------
Frank T. Cary
/s/ Michael D. Casey Director
--------------------------------
Michael D. Casey
/s/ Arthur Hull Hayes, Jr. Director
--------------------------------
Arthur Hull Hayes, Jr.
/s/ Gilla Kaplan Director
--------------------------------
Gilla Kaplan
Director
--------------------------------
Richard C.E. Morgan
/s/ Walter L. Robb Director
--------------------------------
Walter L. Robb
/s/ James R. Swenson Controller (Chief
-------------------------------- Accounting Officer)
James R. Swenson
EXHIBIT INDEX
-------------
Exhibit Description of Exhibit
------- -----------------------
5.1 Opinion of Proskauer Rose LLP.
23.1 Consent of KPMG LLP.
23.2 Consent of Proskauer Rose LLP (included in Exhibit 5.1).
24.1 Power of Attorney (included in signature pages).
99.1 Celgene 1998 Stock Incentive Plan, as amended and restated.
99.2 Celgene Corporation 1995 Non-Employee Directors' Incentive Plan.